gdc

Cancer Research

Becoming a Patient Advocate After a Multiple Myeloma Diagnosis
Cancer ResearchMultiple MyelomaPatient Advocacy
Jack Aiello, multiple myeloma survivor, looks at the importance of patient advocacy and breaks down the different areas of advocacy.
Important Changes in Lung Cancer Therapy Reported at ESMO 2017
Cancer ResearchImmunotherapyLung Cancer
Significant developments in the treatment of lung cancer were reported at the 2017 annual meeting of the European Society for Medical Oncology (ESMO) in Madrid, Spain.
Why Should I Consider Participating in a Clinical Trial for New Cancer Immunotherapies?
Cancer ResearchClinical TrialsImmunotherapy
According to the Cancer Research Institute, only 3% to 6% of eligible patients with cancer participate in clinical trials in the United States. Read the reasons why clinical trials are a great option to consider.
Meeting of Hearts & Minds: Connecting Patients with Cancer Researchers
Cancer ResearchMultiple Myeloma
It’s quite common for patients with cancer to form strong bonds with their oncologists. But it’s not often that patients form connections with researchers, the very scientists who develop cancer therapies that help patients, especially patients facing cancer.
Triathlete, Nonsmoker, and a Lung Cancer Diagnosis: Kirk Smith's Quest to Empower Cancer Research & Patient Self-Education
Cancer ResearchLung Cancer
It’s hard to believe that Kirk Smith, the 54-year-old owner of an advertising company, a triathlete, and a runner for the past 15 years or so, has lung cancer.
Including the Patient Voice in Clinical Trials Design
Cancer ResearchClinical TrialsPatient Advocacy
The role of patients in clinical trials is slowly changing, but enlightening more pharmaceutical companies about the value of the patient’s perspective in designing clinical trials is still a challenge.

Results 1 - 6 of 6

Subscribe to CONQUER: the patient voice® magazine

Receive timely cancer news & updates, patient stories, and more.

Country